The CSL Centenary Fellowships for early-mid career medical researchers are high-value awards available to Australians who wish to continue a career in medical research in Australia. Two individual five-year $1.25 million fellowships are awarded each calendar year.
This $25 million program was established by CSL Limited in its Centenary year to support Australia’s best and brightest biomedical researchers—fostering excellence in medical research by supporting mid-career scientists to pursue world-class research at an Australian institution.
The 2021 Fellows will be announced on Thursday 15 October, 2020.
For more information, contact Niall Byrne on email@example.com 0417 131 977 or (03) 9398 1416.
More about the Fellowships at: www.csl.com.au/centenary/fellowships.htm
CSL Limited is a global specialty biotechnology company that researches, develops, manufactures and markets products to treat and prevent serious human medical conditions.
CSL Media Release
CSL is proud to announce the establishment of a new flagship $25 million fellowship program for early stage and translational research in Australia.
The announcement was made last night by CSL’s Chief Executive Officer, Mr Paul Perreault, at the CSL Centenary Celebration Gala. Mr Perreault also announced that the highly respected molecular biologist, Professor Ashley Dunn, will Chair the Selection Committee.